A look back at Pharma in 2010

With 2010 coming to a close, FiercePharma is publishing our annual year-in-review issue. We're taking a look back at the past 12 months to identify the major trends--such as recalls, settlements and the emerging markets grab--that shaped the pharma industry this year.

FiercePharma is taking our annual year-end break and won't be published tomorrow or the last week of December. But you can visit www.fiercepharma.com for breaking news or check out our special reports archive to catch up on articles you may have missed. We'll be back to our regular schedule on Monday, January 3rd and look forward to sharing another year of pharma news with you in 2011. Happy holidays! - Maureen (twitter | email)

Suggested Articles

Astellas and Seattle Genetics are out with Padcev-Keytruda combo data that may be good enough to snag an expedited regulatory review, analysts say.

Distributors had offered billions of dollars to wrap up opioid litigation, but that effort has suffered a major setback, WSJ reports.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.